Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | FADS1 | O60427 | 1/20 | 0.31 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.30 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.30 |
| ▸ | F10 | P00742 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3039862 | 0.83 | MAOA (0.42) | MAOAFADS1PDE3BPDE3A | |
| SCHEMBL3039863 | 0.83 | MAOA (0.39) | MAOAFADS1PDE3BPDE3AF10 | |
| SCHEMBL3042127 | 0.78 | MAOA (0.72) | MAOAF10 | |
| SCHEMBL3043319 | 0.75 | MAOA (0.40) | MAOAFADS1PDE3BPDE3AF10 | |
| SCHEMBL6691654 | 0.74 | MAOA (0.35) | MAOAFADS1 | |
| SCHEMBL3035461 | 0.73 | FADS1 (0.37) | MAOAFADS1PDE3BPDE3A | |
| SCHEMBL6688290 | 0.73 | MAOA (0.35) | MAOAFADS1F10 | |
| SCHEMBL3041907 | 0.72 | FADS1 (0.31) | MAOAFADS1 | |
| SCHEMBL3042118 | 0.70 | MAOA (0.55) | MAOAF10 | |
| SCHEMBL3041904 | 0.69 | FADS1 (0.31) | MAOAFADS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1478629-A1 | N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES AND THEIR DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | PHARMACIA & UPJOHN COMPANY (US) | 2004-11-24 | — | — | EP | disclosed |
| WO-2003072553-A1 | N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES AND THEIR DERIVATES AND THEIR USE AS ANTIBACTERIALS | PHARMACIA & UPJOHN COMPANY (US) | 2003-09-04 | — | — | WO | disclosed |